Department of Surgery, The Catholic University of Korea, College of Medicine, Seoul, Korea.
World J Surg Oncol. 2010 Oct 11;8:86. doi: 10.1186/1477-7819-8-86.
The benefits of preoperative 18FDG-PET/CT for gastric cancer remain uncertain. The aim of this study was to investigate the effects of preoperative 18FDG-PET/CT on the surgical strategy for locally advanced gastric cancer retrospectively.
From January 2007 to November 2008, 18FDG-PET/CT was performed in 142 patients who had been diagnosed with advanced gastric cancer by computed tomography or gastrofiberscope findings.
Detection rates were 88.7% (126/142) for primary tumors and 24.6% (35/142) for local lymph nodes (LN). Nine patients with metastatic lesions underwent induction chemotherapy without operation. Of 133 patients subjected to operation, positive FDG uptake in primary tumors (p=0.047) and local lymph nodes (p<0.001) was related to non-curable operations. The mean standard uptake value (SUV) of primary tumors of patients who underwent non-curable operations was significantly higher than that of patients with curable operations (p=0.001). When the SUV was greater than 5 and FDG uptake of LN was positive, non-curable operations were predicted with a sensitivity of 35.2%, a specificity of 91.0% and an accuracy of 76.7%.
High SUV of the primary tumor and positive FDG uptake in local lymph nodes at PET/CT could predict non-curative resection in locally advanced gastric cancer. Therefore, information from preoperative PET/CT can help physician decisions regarding other modalities without laparotomy.
术前 18FDG-PET/CT 对胃癌的益处仍不确定。本研究旨在回顾性研究术前 18FDG-PET/CT 对局部进展期胃癌手术策略的影响。
2007 年 1 月至 2008 年 11 月,对经 CT 或胃镜检查诊断为进展期胃癌的 142 例患者进行 18FDG-PET/CT 检查。
原发肿瘤的检出率为 88.7%(126/142),局部淋巴结(LN)的检出率为 24.6%(35/142)。9 例有转移病灶的患者行诱导化疗而未行手术。133 例接受手术的患者中,原发肿瘤(p=0.047)和局部淋巴结(p<0.001)摄取 FDG 与不可治愈手术有关。行不可治愈手术的患者原发肿瘤的平均标准摄取值(SUV)显著高于可治愈手术的患者(p=0.001)。当 SUV 大于 5 且 LN 摄取 FDG 阳性时,不可治愈手术的预测敏感性为 35.2%,特异性为 91.0%,准确性为 76.7%。
PET/CT 中原发肿瘤的高 SUV 和局部淋巴结摄取 FDG 可预测局部进展期胃癌不能治愈性切除。因此,术前 PET/CT 可提供无剖腹探查的其他治疗方法的信息,有助于医生决策。